Post

Ikena further sheds staff and pipeline in a bid to maximise value

For the second time this year, Boston-based Ikena Oncology has announced plans for workforce reduction and pipeline prioritisation. The company plans …

Amylyx’s AMX0035 may excel in Wolfram syndrome

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive, fatal neurodegenerative condition characterised by muscle weakness, atrophy, and spasticity, arising from …

How cell and gene therapy are evolving

The progress of advanced therapeutics in recent years, especially in oncology, have been so promising many are starting to use …

FIRE1 implants first patient with vessel sensor in Ireland

The first patient in Ireland has been implanted with FIRE1’s system, which monitors an important warning sign of congestive heart …

Baxter touts positive data from four-year haemodialysis study 

Baxter has announced positive data showing that patients using its expanded haemodialysis therapy, HDx with the Theranova dialyser, had a …